Related Experiment Video
Updated: May 15, 2026
Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Daptomycin versus vancomycin in treatment of methicillin-resistant Staphylococcus aureus meningitis in an
Selin Bardak-Ozcem1, Tuncer Turhan, Oguz Resat Sipahi
1Ege University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.
Abstract:
In this study, we aimed to compare the antibacterial activities of daptomycin and vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) meningitis (induced by MRSA strain ATCC 43300) in an experimental rabbit meningitis model. After an 8-h period of treatment, bacterial counts decreased significantly in both treatment groups compared to the control group (P < 0.05). However, there was no statistically significant difference between treatment groups. Our results suggest that the antibacterial activity of daptomycin is similar to vancomycin for treatment in the experimental MRSA meningitis model in rabbits.
Insights
Daptomycin and vancomycin show similar antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) meningitis in rabbits. Both antibiotics significantly reduced bacterial counts in this experimental model.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Meningitis caused by methicillin-resistant Staphylococcus aureus (MRSA) presents a significant therapeutic challenge.
- Vancomycin is a standard treatment, but concerns about resistance and efficacy persist.
Purpose of the Study:
- To compare the in vivo antibacterial efficacy of daptomycin and vancomycin.
- To evaluate their effectiveness in treating experimental MRSA meningitis in a rabbit model.
Main Methods:
- An experimental rabbit meningitis model was established using MRSA strain ATCC 43300.
- Rabbits were treated with either daptomycin or vancomycin for 8 hours.
- Bacterial counts in cerebrospinal fluid were assessed post-treatment.
Main Results:
- Both daptomycin and vancomycin treatments resulted in significant reductions in bacterial counts compared to the control group (P < 0.05).
- No statistically significant difference in antibacterial activity was observed between daptomycin and vancomycin.
Conclusions:
- Daptomycin demonstrates comparable antibacterial activity to vancomycin in the treatment of experimental MRSA meningitis.
- These findings suggest daptomycin as a potential alternative for MRSA meningitis treatment in this model.
